Clinical trials
Completed Phase 1 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
570 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 14 |
| 2001 | 10 |
| 2002 | 9 |
| 2003 | 14 |
| 2004 | 14 |
| 2005 | 22 |
| 2006 | 17 |
| 2007 | 27 |
| 2008 | 24 |
| 2009 | 32 |
| 2010 | 25 |
| 2011 | 24 |
| 2012 | 17 |
| 2013 | 30 |
| 2014 | 28 |
| 2015 | 31 |
| 2016 | 39 |
| 2017 | 29 |
| 2018 | 43 |
| 2019 | 18 |
| 2020 | 23 |
| 2021 | 21 |
| 2022 | 10 |
| 2023 | 11 |
| 2024 | 8 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 570 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 27 |
| AstraZeneca | 19 |
| Eli Lilly and Company | 16 |
| Pfizer | 15 |
| Boehringer Ingelheim | 14 |
| Novartis Pharmaceuticals | 14 |
| Memorial Sloan Kettering Cancer Center | 13 |
| Merck Sharp & Dohme LLC | 12 |
| Roswell Park Cancer Institute | 12 |
| AbbVie | 9 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 570 |
| Lung Neoplasms | 157 |
| Neoplasms | 102 |
| Breast Neoplasms | 91 |
| Colorectal Neoplasms | 81 |
| Melanoma | 79 |
| Ovarian Neoplasms | 75 |
| Carcinoma, Renal Cell | 68 |
| Pancreatic Neoplasms | 68 |
| Small Cell Lung Carcinoma | 62 |
Trials
Showing 1 to 25 of 570. Each trial links to its page on Pharma Observatory.
470 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.